Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Proteome Sciences Paying £12.6M For Aventis' Proteomics Division

June 5, 2002

By Aaron Lorenzo

Alliance Gets Approval For Ultrasound Imaging Agent

June 4, 2002

By Aaron Lorenzo

Alliance Gets Approval For Ultrasound Imaging Agent

June 4, 2002

By Aaron Lorenzo

Proteome Sciences Paying £12.6M For Aventis' Proteomics Division

June 3, 2002

By Aaron Lorenzo

Proteome Sciences Paying £12.6M For Aventis' Proteomics Division

June 3, 2002

By Aaron Lorenzo

Visible Genetics Considers Sale Of Company, Lowers Estimates

May 31, 2002

By Aaron Lorenzo

Visible Genetics Considers Sale Of Company, Lowers Estimates

May 31, 2002

By Aaron Lorenzo

Serenex Rationalizing Proteomics To Find, Revitalize Compounds

May 29, 2002

By Aaron Lorenzo

Serenex Rationalizing Proteomics To Find, Revitalize Compounds

May 29, 2002

By Aaron Lorenzo

Tercica Raises $21.5M, Gains Rights To IGF-1 From Genentech

May 24, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 15, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...